A Closer Look to the Most Frequent Travelers’ Disease: A Systematic Update on Travelers’ Diarrhea

Authors

Health Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran

Abstract

The present study, wants to highlight and review the most prevalent disease amongst travelers. In the current review, an updated review regarding epidemiology, involved pathogens, and a brief review of current evidence-based guidelines for prevention and treatment of this disease are provided. A distinguishing feature of the current review is the discussion of the impacts of irritable bowel syndrome, as one of the most prevalent gastrointestinal diseases, on travelers’ diarrhea pattern. Moreover, evidence-based data was the primary source for all parts of the current study. A recent review of GeoSentinel Surveillance Network database, with a very large sample size was the basis for epidemiologic appraisals.

Keywords


DuPont HL, Khan FM. Travelers’ diarrhea: epidemiology, microbiology, prevention, and therapy. J Travel Med 1994;1:84–93.
Pitzinger B, Steffen R, Tschopp A. Incidence and clinical features of traveler’s diarrhea in infants and children. Pediatr Infect Dis J 1991; 10:719–723.
Peltola H, Kyronseppa H, Holsa P. Trips to the south—a health hazard. Morbidity of Finnish travelers. Scand J Infect Dis 1983;15:375–81.
Castelli F, Pezzoli C, Tomasoni L. Epidemiology of travelers’ diarrhea. J Travel Med. 2001;8:S26– S30.
Steffen R, van der Linde F, Gyr K, Schar M. Epidemiology of diarrhea in travelers. JAMA. 1983;249:1176–80.
Ericsson CD, DuPont HL. Travelers’ diarrhea: approaches to prevention and treatment. Clin Infect Dis. 1993;16:616–24.
Kollaritsch H. Traveler’s diarrhea among Austrian tourists in warm climate countries: I. Epidemiology. Eur J Epidemiol. 1989;5:74–81.
Steffen R. Epidemiologic studies of travelers’ diarrhea, severe gastrointestinal infections, and cholera. Rev Infect Dis. 1986;8(Suppl 2):S122–S130.
von Sonnenburg F, Tornieporth N, Waiyaki P, Lowe B, Peruski LF Jr, DuPont HL, et al. Risk and etiology of diarrhea at various tourist destinations. Lancet. 2000; 356:133–4.
Steffen R. Epidemiology of travelers’ diarrhea. Scand J Gastroenterol Supp. 1983; 84:5–17.
Steffen R, Tonieporth N, Clemens SAC, Chatterjee S, Cavalcanti AM, Collard F, et al. Epidemiology of travelers’ diarrhea: details of a global survey. J Travel Med. 2004;11:231–7.
Steffen R. Epidemiology of traveler’s diarrhea. Clin Infect Dis. 2005; 41:S536–S540.
Ahlm C, Lundberg S, Fesse K, Wistrom J. Health problems and self-medication among Swedish travelers. Scand J Infect Dis. 1994; 26:711–7.
Hill DR. Occurrence and self-treatment of diarrhea in a large cohort of Americans traveling to developing countries. Am J Trop Med Hyg. 2000; 62:585–9.
Cobelens FG, Leentvaar-Kuijpers A, Kleijnen J, Coutinho RA. Incidence and risk factors of diarrhoea in Dutch travellers: consequences for priorities in pre-travel health advice. Trop Med Int Health. 1998; 3:896–903.
Hachiya M, Kikuchi H, Mizoue T. Descriptive epidemiology of travel-associated  diarrhea based on surveillance data at Narita International Airport. J Travel Med. 2010 Mar-Apr;17(2):105-10.
JTB report 2006. All about Japanese overseas travelers, 2006. Japan Tourism Marketing Co., 2006.
Market insight. Nihonjin Kaigai Ryoko Shijo no Doko. (in Japanese) Tokyo: Zaidan Hojin Nihon Kotsu Kosha, 2006.
Evans MR, Shickle D, Morgan MZ. Travel illness in British package holiday tourists: prospective cohort study. J Infect. 2001; 43:140–7.
Redman CA, MacLennan A, Wilson E, Walker E. Diarrhea and respiratory symptoms among travelers to Asia, Africa, and south and central America from Scotland. J Travel Med. 2006;13:203–211.
Kollaritsch H. Traveler’s diarrhea among Austrian tourists in warm climate countries: I. Epidemiology. Eur J Epidemiol. 1989;5:74–81.
Ekdahl K, de Jong B, Andersson Y. Risk of travel- associated typhoid and paratyphoid fevers in various regions. J Travel Med. 2005;12:197–204.
Drossman DA, Camilleri M, Mayer EA, Whitehead WE, 2002. AGA technical review on irritable bowel syndrome. Gastro- enterology. 123: 2108–31.
Hungin AP, Chang L, Locke GR, Dennis EH, Barghout V. Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Aliment Pharmacol Ther. 2005;21:1365–75.
DuPont AW. Post-infectious irritable bowel syndrome. Curr Gastroenterol Rep. 2007;9:378–84.
Neal KR, Barker L, Spiller RC. Prognosis in post-infective irritable bowel syndrome: a six year follow up study. Gut. 2002;51:410–13.
Parry S, Forgacs I. Intestinal infection and irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2005;17:5–9.
Taylor DN, Bourgeois AL, Ericsson CD, Steffen R, Jiang ZD, Halpern J, Haake R, DuPont HL. A randomized, double- blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers’ diarrhea. Am J Trop Med Hyg. 2006;74:1060–6
Connor BA. Sequelae of traveler’s diarrhea: focus on postinfectious irritable bowel syndrome. Clin Infect Dis. 2005;41(Suppl 8): S577–S586.
Okhuysen PC, Jiang ZD, Carlin L, Forbes C, DuPont HL. Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico. Am J Gastroenterol. 2004;99:1774–8.

Törnblom H, Holmvall P, Svenungsson B, Lindberg G. Gastrointestinal symptoms after infectious diarrhea: a five-year follow-up in a Swedish cohort of adults. Clin Gastroenterol Hepatol. 2007;5:461–4.
Stermer E, Lubezky A, Potasman I, Paster E, Lavy A. Is traveler’s diarrhea a significant risk factor for the development of irritable bowel syndrome? A prospective study. Clin Infect Dis. 2006;43:898–901.
Peltola H, Kyronseppa H, Holsa P. Trips to the South e a health hazard. Morbidity of Finnish travellers. Scand J Infect Dis. 1983;15(4):375e81.
Steffen R, Collard F, Tornieporth N, Campbell-Forrester S, Ashley D, Thompson S, et al. Epidemiology, etiology, and impact of traveler’s diarrhea in Jamaica. JAMA. 1999 Mar 3; 281(9):811e7.
Jiang ZD, Lowe B, Verenkar MP, Ashley D, Steffen R, Tornieporth N, et al. Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay). J Infect Dis. 2002 Feb 15;185(4):497e502.
Ericsson CD. Travelers’ diarrhea. Int J Antimicrob Agents. 2003 Feb;21(2):116e24.
Behrens RH, Collins M, Botto B, Heptonstall J. Risk for British travelers of acquiring hepatitis A. BMJ. 1995 Jul 15;311(6998):193.
Provost S, Gagnon S, Lonergan G, Bui YG, Labbe AC. Hepatitis A, typhoid and malaria among travelers e surveillance data from Quebec (Canada). J Travel Med. 2006 Jul Aug;13(4):219e26.
Ryan ET, Wilson ME, Kain KC. Illness after international travel. N Engl J Med. 2002 Aug 15;347(7):505e16.
Ericsson CD. Travelers’ diarrhea. Epidemiology, prevention, and self-treatment. Infect Dis Clin North Am. 1998 Jun;12(2):285e303.
Johnson PC, Hoy J, Mathewson JJ, Ericsson CD, DuPont HL. Occurrence of Norwalk virus infections among adults in Mexico. J Infect Dis. 1990 Aug;162(2):389e93.
Kish MA. Guide to development of practice guidelines. Clin Infect Dis. 2001;32:851-4. 
DuPont HL, Mattila L. Antimicrobial treatment: an algorithmic approach. In: Ericsson CD, DuPont HL, Steffen R, eds. Travelers’ diarrhea. Hamilton, Ont.: BC Decker, 2003:227–37.
Adachi JA, Ostrosky Zeichner L, DuPont HL, Ericsson CD. Empirical antimicrobial therapy for traveler’s diarrhea. Clin Infect Dis. 2000; 31:1079–83.
Hoge CW, Gambel JM, Srijan A, Pitarangsi C, Echeverria P. Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. Clin Infect Dis. 1998;26:341–5.
Adachi JA, Ericsson CD, Jiang ZD, DuPont MW, Martinez-Sandoval F, Knirsch C, et al. Azithromycin found to be comparable to levofloxacin for the treatment of US travelers with acute diarrhea acquired in Mexico. Clin Infect Dis. 2003;37:1165–71.
Stauffer WM, Konop RJ, Kamat D. Traveling with infants and young children. Part III: travelers’ diarrhea. J Travel Med. 2002;9:141–50.